Antibiotic use and effectiveness in community acquired infection

Project ID

SDE_YH_PROJ_193

Lay Summary

Community acquired pneumonia (CAP) is a lung infection that begins outside of hospital. Antibiotics can be an effective treatment, but can also cause side effects, so it is important that they are used only when necessary. Some antibiotics are associated with more severe side effects than others. The medicines regulator in the UK has attempted to reduce the inappropriate prescribing of a certain group of antibiotics called fluoroquinolones, because of their side effects. In this research we will look at the impact of measures by the UK medicines regulator on antibiotic prescribing in practice. This will help us to understand if these measures are working. We also do not know what the most effective antibiotics are for patients with CAP. Clinical guidelines are available, but the evidence used to make these recommendations is incomplete. Antibiotic effectiveness depends on the bug causing the infection, but this is rarely known when antibiotics are first prescribed. Therefore, we will also compare the impact of different antibiotic combinations on patient outcomes. We will also use data about patients such as their investigation results, history of infections, and their age to estimate what bugs are most likely to be causing infection.

Trading name

Bradford Teaching Hospitals FT

Legal name of contracting organisation

Bradford Teaching Hospitals FT

Date of counter-signed DAA/DSA

12/10/2025

Project Status

In progress

HRCS Category

Generic Health Relevance

Multiple SDE indicator

No

Is this SDE Lead?

Yes

Name of SDE Parties

Yorkshire and Humber Secure Data Environment

Privacy

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

For more information, please visit our Privacy Policy.